Top

GoCART Call for Research Proposals 2023, announcement of the two winning proposals

… collaborations across stakeholders in the field of CAR T-cell therapies. The selection committee was composed by … selection committee: The Role of Bridging Therapy before CAR-T Cell Therapy in Diffuse Large B-cell Lymphoma: An …

Ruth Clout reappointed for a second term as Cellular Therapy & Immunobiology Working Party Nurse

… of the EBMT meetings, including the Annual Meetings and CAR-T Meetings where I have presented and chaired sessions. I …

EBMT 2025 Annual Meeting - Jon J. van Rood Award winners

… TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome Oral … responses leading to ICANS (Neurotoxicity associated with CAR T cell therapy) and ultimately improve immunotherapies. …

14th EBMT Lymphoma Working Party Educational Course

… gave some perspective as to where we are currently. The CAR-T cell talk provided an excellent overview of this exciting …

Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP)

… Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP) …

My paper of the Month - Building the Future Management of Follicular Lymphoma with T-Cell Redirecting Strategies

… Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies ” published in Blood .   * … refractory patients, including chimeric antigen receptor (CAR) T-cell therapies and bispecific antibodies (BsAbs) as … of recently approved T-cell redirection therapies, such as CAR T-cells and BsAbs, to improve patient outcomes. In R/R FL …

Activity report 2022 of the Pharmacists Committee

… the Implementation and Operational Management of Marketed CAR-T Cell Therapy – submitted for publication. … Activity Report …

E-learning courses & webinars 2020

… of COVID-19 pandemic on nurses: experiences and tips CAR-T Cell and COVID-19 and how and when to restart the … patients with focus on stem cell transplantation and CAR-T cells (EBMT/ASTCT) Strategies to prevent and handle …

Plenary and Special Sessions at EBMT 2019

… showed that either post-transplant cyclophosphamide or T cell depleted approaches can offer cure, even for advanced … Therapy in Children” New developments in the field of CAR cell therapy Less than two months after the 1 st and enormously successful European Symposium on CAR-T Cells, co-organized in Paris by the EBMT and the EHA, …

Thérapie par cellules CAR-T dans les maladies auto-immunes en tant qu'indication principale ou concomitante : une étude en deux étapes au nom du groupe de travail ADWP et du groupe de travail CTIWP de l'EBMT

… Thérapie par cellules CAR-T dans les maladies auto-immunes Veuillez répondre aux … atteints de maladies auto-immunes (MA) traités par CAR-T. Informations de contact Caractéristiques du centre …